Q2 2023 Thor Medical ASA Earnings Call Transcript
(foreign language) I'm pleased to be here to tell you about the [redirection] of Nordic Nanovector (inaudible). We're very proud that we have managed to get this deal in the first half of this year.
These are the highlights. As you will see, we had to close down PARADIGME and reduce cost to preserve the cash, the acquisition of Thor Medical, an emerging supplier of alpha-emitters. We managed to reach an agreement with as you accepted at the AGM on the 28th of June, and the transaction was closed just after the half of the year. And we are now strategic repositioning the company, which Alf Bjørseth will tell you more about. And then our new CFO, Brede Ellingsæter will come and tell you all about the financials.
I'm just here to present since I was the only one within the company. In the first half year, as you remember, there was an extraordinary General Meeting who elected a new Board. And then again, the Board prioritized to hire me as a former Chairman of the Board of the company. I knew the company. So we worked closely
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |